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Abstract
Introduction. Ketamine is an essential medicine used as an anesthetic in low and 
middle-income countries and in veterinary medicine. Recreational use is widespread 
throughout the world, especially owing to its lower price compared to other substances. 
In Western countries its use has been mainly linked to subpopulations of young people 
who use drugs recreationally. Ketamine misuse is associated with amnesia, dependence, 
dissociation, lower urinary tract dysfunction and poor impulse control. Regular ketamine 
use is associated with abdominal pains. 
Aims. The aims of this study are to analyze characteristics and main symptoms of ket-
amine abusers attending emergency departments (EDs) in the metropolitan area of Bo-
logna, Emilia-Romagna Region, northern Italy.
Methods. We identified 74 records of ketamine-related visits: 30% female; 22% non-
natives; mean age 25.6 years. Forty-two percent reported ketamine use alone, 46% re-
ported the use of other illegal substance (cocaine 19%, heroin 18%), 26% alcohol misuse.
Results. The most common reported symptoms were neurological (soporous state 18%, 
agitation 14%, confusion 7%, panic attacks 7%, mydriasis 7%, tremors 7%), gastro-in-
testinal (abdominal pain 15%, vomiting 11%), urological (6.8%) and cardiac (palpita-
tions 5%, chest pain 5%). Complications secondary to falls and cuts (7%) were the most 
frequent trauma complications. We highlight a significant number of visits regarding 
suicide attempts (10%) and overdose (4%).
Conclusions. The results highlight a particular population of problematic ketamine us-
ers identified using the hospital’s ICT system. In particular, poly-drug users who con-
sume ketamine in combination with heroin or cocaine presenting to the ED represent 
a specific target for targeted prevention projects on non-lethal overdoses and suicide 
attempts.
INTRODUCTION
Ketamine is an essential medicine, a remarkably safe 
anesthetic that has been used worldwide for over half 
a century. The drug does not depress respiration or 
the cardiovascular system and can be administered by 
trained non-physicians. Ketamine was first synthesized 
in 1962 and patented as an anesthetic in 1966. It was 
used in the Vietnam War for its capacity to induce a dis-
sociative state in wounded soldiers; is still used as a bat-
tlefield anesthetic in low and middle-income countries 
and in veterinary medicine [1]. It is mainly obtained in 
powder form and administered by sniffing or inhaling. 
Other forms of ingestion include intramuscular routes 
or occasionally intravenous ones [2]. 
Illicit manufacturing, trafficking, and use of ketamine 
appear to have begun on a large scale in several Asian 
countries, and it has subsequently spread to other re-
gions [3]. Recreational use is widespread throughout 
the world, but more common in the East and South-
East Asia, especially owing to its lower price compared 
to other substances. In Western countries its use has 
been mainly linked to subpopulations of young people 
who use drugs recreationally and to the so-called ‘rave’ 
culture, but reports have indicated that ketamine is be-
ing used in social settings in many parts of the world, 
such as nightclubs and dance parties [4]. Study results 
report a utilization rate ranging from 0.1% and 4% in 
the general population, higher among the nightlife and 
entertainment places [5].
In Italy, on the basis of seizures carried out, it is as-
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sumed that the phenomenon is linked to the arrival 
of liquid ketamine from India and that the abuse by 
young clubbers or ravers is on the rise [6]. Further-
more, a study on new drugs conducted by the Istituto 
Superiore di Sanità shows that ketamine is also used to 
cut MDMA [7]. Regarding study results, 1.1% (males 
1.4%, females 0.8%) of a representative sample of Ital-
ian students aged 15-19 reported lifetime ketamine use 
[8]; 11% of 2015 people interviewed during raves and 
concerts in northern Italy [9], 5% of 354 residents aged 
18-25 in Emilia Romagna and Veneto region [10] and 
4% of 392 students aged 16-17 declared they had used 
ketamine at least once in their life [11]. 
Psychologically, the acute use of ketamine caused 
hallucinations, symptoms of psychosis, delusion, agita-
tion, confusion, and memory impairment. Many side 
dose-dependent effects (nausea and vomiting, bizarre 
dreams) have been documented and some of them have 
persisted for several days after administration. At low 
doses it causes euphoria, intensification of feelings of 
empathy and induces distortion of time and space, hal-
lucinations and slight dissociative effects. At high doses 
it causes dissociative effects, hallucination, intoxication 
and pre/death experiences, known as “K hole”. Long-
term recreational use of ketamine can be associated 
with the development of dependence and tolerance, 
and there is evidence of gastro-intestinal toxicity (ab-
dominal pain and abnormal liver function tests) and 
urological disorders [12], particularly hemorrhagic cys-
titis [13]. 
The main consequences for social behavior stem di-
rectly from the physical and psychological effects of 
ketamine and the tendency towards compulsive use by 
some users. The sudden anesthetic effects of ketamine 
create a high risk for accidents and make driving par-
ticularly dangerous following consumption. The main 
effects depend on the dose, the administration route 
and the context of consumption [14]. 
Ketamine misuse is associated with amnesia, depen-
dence, dissociation, lower urinary tract dysfunction and 
poor impulse control [5]. Regular ketamine use is as-
sociated with vague abdominal pains of unknown etiol-
ogy, colloquially termed “K cramps” [12].
Although a specific withdrawal syndrome has not yet 
been identified, substance dependence develops rap-
idly. While there are limited data regarding the physi-
cally addictive aspects of ketamine, it may result in a 
dependence, especially as tolerance to its effects builds 
very rapidly [15]. Many frequent users are concerned 
about addiction and report trying but failing to stop us-
ing ketamine [16]. 
Because of the illegal nature of the drug, we may 
never know how many people use ketamine, or the pre-
cise correlation between chronic high-dose intake and 
symptoms. Previous studies have suggested that 20% of 
users may develop symptoms but there is no consistent 
safe level or time frame for regular users [17]. 
From studies targeted on emergency department 
(ED) presentations of patients after the deliberate abuse 
of ketamine, common complaints include anxiety, chest 
pain, and palpitations; the most frequent complications 
are severe agitation and rhabdomyolysis [18]. From a 
study on acute clinical presentations of ketamine abus-
ers in fifteen EDs in Hong Kong, the typical ketamine 
abuser was young (median age 22 years) and presented 
with impaired consciousness, abdominal pain, lower 
urinary tract symptoms, or dizziness, together with un-
explained high blood pressure or tachycardia [19]. 
In order to identify prevention strategies targeted on 
this population with high-risk behaviors, but difficult to 
reach by addiction services, accesses to 11 EDs between 
1 January 2009 and 30 June 2019 were examined. 
The aims of this retrospective study are to analyze 
characteristics and main symptoms of ketamine abus-
ers attending EDs in the metropolitan area of Bologna, 
Emilia-Romagna Region, northern Italy.
METHODS
A cross-sectional study design was used. The inclu-
sion criteria were a history of ketamine use within 48 
hours. Patients presenting more than 48 hours after the 
last ketamine intake were excluded.
The Bologna metropolitan area has activated a rapid 
drug alert system. This is coordinated by the metro-
politan epidemiological observatory on pathological 
dependency (OEMDP), which links public and private 
dependency services, EDs, the 118 emergency services, 
the various police forces, and the death registry. The 
primary aim is for professionals and local operative 
units to share digitalized information on substances 
in circulation and trauma events (fatal and nonfatal 
overdoses). The system comprises a single database fed 
from various different sources and is accessible online 
via a protected web site. From the data available, the 
OEMDP studies the situation and analyzes patient 
characteristics and service contact details. 
We searched the hospital patient database for all con-
sultations related to ketamine use in 11 EDs between 
1 January 2009 and 30 June 2019, in the metropolitan 
area of Bologna, Emilia-Romagna Region, northern 
Italy.
All the records collected from each ED were selected 
from presentation databases and using key words from 
ICD-10. A content analysis of the records was per-
formed by a multidisciplinary team comprising physi-
cians, sociologists, psychiatrists and epidemiologists. 
All the information was obtained retrospectively, and 
data collection forms were abstracted for each case. 
Only cases of ketamine intoxication, defined as medical 
problems associated with self-reported ketamine use, 
were enrolled. The term “ketamine” was specifically re-
searched in each record. 
Information on ED arrival came from the informa-
tion recorded electronically upon presentation at the 
ED: sex, age, nationality, residence, day, time and TRI-
AGE code.
Information on the reasons for ED admittance, hos-
pitalization and the substances used was obtained by 
analyzing the ED case file. We highlight that more than 
one substance may have been used.
The distribution of ketamine complications was as-
sessed with standard descriptive statistics. The con-
tinuous and categoric variables were analyzed with 
Student’s T test and the chi-square test, respectively. 
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Significance level was set at 0.05. Stata 15.0 was used 
for the statistical analysis.
RESULTS
Out of 2 890 959 patient accesses aged 16-49 years 
referring to ED between 1 January 2009 and 30 June 
2019, we obtained 7897 visits regarding illegal sub-
stance use, among which we identified 74 records of 
ketamine-related visits: 29.7% female; 58.1% non-resi-
dents; 21.6% non-natives; mean age 25.6 years. Most 
of them were aged between 20 and 24 years (39.2%) 
and between 25 and 29 years (29.7%), while 16% were 
less than 20 years and 16% over 29 years. The highest 
percentage of visits was in 2012 (7 cases) and in 2013 (7 
cases). Forty-two percent reported ketamine use alone, 
46% reported the use of other illegal substances (co-
caine 18.9%, heroin 17.6%, cannabis 12.2%, amphet-
amines 9.5%, MDMA 9.5%, LSD 4.1%, opium 2.7%), 
25.7% alcohol abuse, 5.4% psychiatric drugs (Table 1). 
Among females we highlight the lower mean age (males 
26.4 years, females 23.7, P 0.04) and the higher per-
centage of opium use (males no cases, females 9.1%, 
P 0.028).
Fifty-three percent accessed at night, 37.8% over the 
weekend, most of visits were in January (15%) and on a 
Sunday (31.1%). Fifteen percent were taken to the ED 
by ambulance, 67.6% was classified as serious during 
the triage (9.5% red code, 58.1% yellow code, 31.1% 
green code, 1.4% white code), 9.5% were admitted to 
the hospital. 
Regarding ketamine use, 77% of patients accessed 
EDs less than 12 hours from the last ketamine intake, 
5.4% self-injected (intramuscular injection) and all the 
others snorted (94.6%)
The most common reported symptoms were neuro-
logical, gastro-intestinal, urological and cardiac (Table 
2). Regarding neurological reported symptoms we high-
light soporific state (17.6%), agitation (13.5%), con-
fusional state (6.8%), panic attacks (6.8%), mydriasis 
(6.8%) and tremors (6.8%). A percentage ranging from 
3% and 5% reported coma, epilepsy, hallucinations, 
dizziness, blurred speeches and neck pain. To note 
that soporific state was more common among females 
(males 11.5%, females 31.8%, P 0.036).
As regards gastro-intestinal symptoms, 15% reported 
abdominal pains and 10.8% vomiting, the latter was 
Table 1 
Metropolitan area of Bologna 01/01/2009-30/06/2018: visits for ketamine use to emergency departments
Total
(74)
Males
(52)
Females
(22)
P
Personal data Non-native (%) 21.6 21.2 22.7 0.881
Non-resident (%) 58.1 55.8 63.6 0.531
Mean age 25.6 26.4 23.7 0.04
Arrival Night (20:00-8:00) 52.7 50.0 59.1 0.474
Weekends (Friday 17:00-Monday 08:00) 37.8 40.4 31.8 0.487
Ambulance 14.9 19.2 4.6 0.105
Triage Red 9.5 11.5 4.6 0.590
Yellow 58.1 53.9 68.2
Green 31.1 32.7 27.3
White 1.4 1.9 -
Ketamine use Acute (within 12h of ketamine use) 77.0 76.9 77.3 0.974
Intramuscular injection 5.4 3.9 9.1 0.362
Cocomitant current drug use Only ketamine 41.9 44.2 36.4 0.531
Alcohol 25.7 23.1 31.8 0.431
Psychiatric drugs 5.4 3.9 9.1 0.362
Illegal substance 46.0 44.2 50.0 0.649
Substance use Cocaine 18.9 23.1 9.1 0.160
Heroin 17.6 15.4 22.7 0.448
Cannabis 12.2 11.5 13.6 0.801
Amphetamines 9.5 7.7 13.6 0.425
MDMA 9.5 9.6 9.1 0.944
LSD 4.1 5.8 - 0.250
Opium 2.7 - 9.1 0.028
Outcome Hospital admission 9.5 13.5 - 0.071
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more common amongst females (males 5.8%, females 
22.7%, P 0.032). As regards cardiac symptoms, 5.4% 
reported palpitations, 5.4% chest pain and 4.1% hyper-
pyrexia. For what concerns other symptoms, 6.8% re-
ported urological complications (renal colic, urine leak, 
hematuria and stranguria). 
Furthermore, we observed some physical complica-
tions regarding suicide attempts (9.5%), traumas, falls 
or cuts (6.8%), overdose (4.4%), injecting complications 
(2.7%) and tongue bites (1.4%). To note that inject-
ing complications were more common among females 
(males no cases, females 9.1%, P 0.028).
Results are reported in Table 3.
DISCUSSION
In this paper we described a large series of ketamine 
users presenting to an acute medial setting over a ten-
year period in northern Italy. The patients treated for 
ketamine represent 9.4 per thousand of the total num-
ber of patients attending the 11 EDs during the study 
period for reasons related to illegal substance use.
This study systematically reviewed and summarized 
visits to EDs for medical problems and trauma com-
plications relating to self-reported ketamine use. Key 
findings include an apparently small number of patients 
who presented to EDs reporting symptoms associ-
ated with ketamine use. The most commonly reported 
symptoms were neurological, although a high number 
of gastro-intestinal, urological and cardiac symptoms 
were also reported. Complications secondary to falls 
and cuts were the most frequent trauma complications. 
Moreover, we highlight a significant number of visits 
regarding suicide attempts and overdose.
This study may have excluded additional patients 
with a history of ketamine use who were treated with-
out medical personnel being aware of their histories. 
Furthermore, the size of the cohort is rather small, thus 
limiting its power to investigate ketamine risk factors. 
These aspects limit the generalizability of the results 
to simple access for ketamine use, and do not allow for 
prevalence estimates. Notwithstanding these limita-
tions, some data emerge that allow us to deepen our 
knowledge of this particular situation, affording useful 
indications when it comes to identifying risk profiles 
and verifying the usefulness of a surveillance system. 
Table 2 
Visits for ketamine use to emergency departments: most common reported symptoms
Total
(74)
Males
(52)
Females
(22)
P
Neurological Soporous state 17.6 11.5 31.8 0.036
Agitation state 13.5 13.5 13.6 0.984
Confusional state 6.8 9.6 - 0.132
Panic attacks 6.8 7.7 4.6 0.622
Mydriasis 6.8 7.7 4.6 0.622
Tremors 6.8 3.9 13.6 0.125
Coma 4.1 5.8 - 0.250
Epilespsy 2.7 3.9 - 0.351
Hallucination 2.7 3.9 - 0.351
Dizziness 2.7 3.9 - 0.351
Blurred speeches 2.7 3.9 - 0.351
Neck pain 2.7 3.9 - 0.351
Cardiovascular Palpitations 5.4 5.8 4.6 0.831
Chest pain 5.4 7.7 - 0.181
Hyperpyrexia 4.1 5.8 - 0.250
Gastro-intestinal Vomiting 10.8 5.8 22.7 0.032
Abdominal pain 14.9 13.5 18.2 0.602
Urological Complications (renal colic, urine leak, hematuria, 
stranguria)
6.8 5.8 9.1 0.603
Table 3 
Visits for ketamine use to emergency departments: other phys-
ical complications
Total
(74)
Males
(52)
Females
(22)
P
Self-harm/suicide 
attempt
9.5 11.5 4.6 0.347
Traumas (falls/cuts) 6.8 9.6 - 0.132
Overdose 4.4 2.1 9.5 10.63
Injecting 
complications
2.7 - 9.1 0.028
Tongue bite 1.4 1.9 - 0.513
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As regards a comparison with Italian literature, the 
data from our study are hard to compare, as they derive 
from a specific study on ED admissions and cannot be 
considered a picture of what is happening in Italy. In 
recent years, many studies on recreational ketamine use 
have been published in Italy, which, in addition to esti-
mating the prevalence of use among young people [6, 
8, 10, 11] have mostly dealt with the phenomenological 
aspects of the experience with the substance by young 
consumers [20-22], in particular the dissociative aspect 
[23-24], the consumption problems [9] and the mean-
ings attributed to use [25]. 
The profile of the typical ketamine user presenting 
to EDs is male, aged around 25, Italian, mainly report-
ing weekend ketamine use at night or during the early 
hours of the day. 
However, a significant portion of subjects present 
to EDs during the other days of the week, both in the 
morning and in the afternoon, and which may suggest 
that ketamine use is less related to social gatherings and 
party events. 
Regarding the use of other substances, in addition to 
alcohol we highlight two distinct and separate consum-
er groups (party drugs attenders and heroin users, both 
sometimes in combination with cocaine), suggesting a 
different ketamine use if related to particular lifestyles 
or to heroin contexts. 
As for the comparison with studies conducted in 
EDs, in a study conducted in Hong Kong percentages 
similar to those of our study are observed regarding 
gender, age, ketamine consumption styles, MDA use, 
amphetamine use and alcohol abuse; the percentage 
of subjects with ketamine use alone was much higher 
(66% vs 42%), the percentage of cocaine use was much 
lower (4% vs 19%) while no cases of heroin, cannabis, 
LSD and opium consumption were reported [17]. In 
a London teaching hospital, Wood et al. recorded 116 
ED presentations involving recreational ketamine use, 
only 11% of which involved ketamine alone, co-ingested 
drugs included ethanol (39%), GHB/GBL (47%), co-
caine (19%) and MDMA (53%) [26].
From the studies it emerges that ketamine is often 
taken alone in private settings to explore its hallucino-
genic effects. The users are aware of the drug’s potency, 
but do not pay attention to long-term negative effects 
[27]. While the use of ketamine was initially confined to 
certain subcultures, it has recently become more main-
stream [16], and the highest endorsed settings of use 
are at home or at a friend’s house [15]. 
Moreover, ketamine has been used as a cutting agent 
for drugs such as cocaine, amphetamine and heroin and 
may be taken by problem opiate users [14]. It is gen-
erally the last substance experimented with [28] and, 
despite those who reported ever using this drug describ-
ing a pattern of occasional use [4], it appears to be a 
substance that had been added to an already extensive 
drug use repertoire [29]. 
Regarding the main symptoms of ketamine abusers 
attending EDs, our results confirm what has been re-
ported by other authors [18, 19, 29], particularly relat-
ing to neurological (soporific state, confusional state, 
blurred speeches, dizziness, agitation state, hallucina-
tion), cardiovascular (chest pain, palpitations), gastro-
intestinal (abdominal pain, vomiting), urological disor-
ders and traumas. 
It should be noted that in our study only 10% of pa-
tients were subsequently hospitalized, as confirmed by 
other EDs studies, which reported that 72% of cases 
were discharged directly from the ED, and no case 
where ketamine alone had been ingested required ad-
mission to critical care [26]. Most of patients developed 
no or only minor complaints [19], and majority of pa-
tients were discharged from the ED within a few hours 
of presentation [18].
Regular ketamine use is associated with vague ab-
dominal pains, with or without vomiting, of unknown 
aetiology, colloquially termed “K cramps” [9, 30].
Agitation, hallucinations and physical harm/trauma 
have been associated with the recreational use of ket-
amine, while cardiovascular features occur less fre-
quently [12]. 
From studies there is evidence from beyond the rec-
reational use setting linking ketamine with urological 
pathology, and it was estimated that up to a third of 
long-term ketamine users may be affected [12, 15].
Some physical complications (overdose, suicide at-
tempt, injecting complications) instead seem typical of 
our cohort, in which nearly half used some other illegal 
substance and one in four misused alcohol. To be noted 
that 30% of the patients using some other illegal sub-
stance also abused alcohol.
Non-fatal emergencies attributed to ketamine use 
are considered to be very rare. The main concern with 
acute ketamine use is the reduction in the user’s aware-
ness and monitoring of their physical environment [31]. 
When ketamine is reported in post-mortem samples, it 
is often either alongside another intoxicant or in the set-
ting of trauma [12, 32].
The international literature reports that for every 
suicide there are between eight and 22 visits to an ED 
for suicidal behavior, so this is the best place to inter-
cept new suicidal cases [33], even if it is observed that 
those attempting suicide are often discharged from the 
ED without undergoing psychiatric assessment, not-
withstanding their suicide risk [34]. Among the seven 
subjects having attempted suicide in our study, 4 used 
cocaine (1 also alcohol) and 3 heroin (2 also alcohol). 
Cocaine and heroin use are known risk factors for sui-
cide, and individuals dependent on these substances are 
more likely to die from suicide than peers [35, 36]. 
Regarding overdoses, we identified three subjects, 
all of whom had used both heroin and alcohol. Among 
heroin users, overdose frequently occurs, and the main 
risk factors associated are age at the start of addiction, 
severity of the addiction and the concomitant use of 
other substances, especially alcohol [37]. Experiencing 
a non-fatal overdose substantially increases the risk of 
subsequent overdose mortality and heroin users admit-
ted to an ED after an overdose are a special, high-risk 
sub-population warranting a distinct prevention meth-
odology [38].
Regarding traumas, the main physical dangers of 
most non-medical ketamine use are believed to arise 
mainly from the setting, or an interaction between the 
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user and the setting of use, as ketamine can leave the 
user in a confused state [39]. This can, for example, re-
sult in burns, falls, drowning, traffic accidents and be-
coming a victim of crimes such as sexual assault [29]. 
It must, however, be considered that although there 
are anecdotal reports of a high risk of accidental injury 
while acutely intoxicated with ketamine, there are few 
scientific data on this risk [16]. 
CONCLUSIONS
Our results highlight a particular population of prob-
lematic ketamine users that can be identified in time 
by using the data present in the hospital’s ICT system. 
In particular, poly-drug users who consume ketamine 
in combination with heroin or cocaine presenting to the 
ED represent a specific target for targeted prevention 
projects on non-lethal overdoses and suicide attempts.
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